Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

AFFECT-EU Urges Routine Atrial Fibrillation Screening for At-Risk Patients

(IN BRIEF) The AFFECT-EU project, culminating in its final event in Brussels, recommends routine atrial fibrillation (AF) screening for individuals at risk, emphasizing its potential to prevent strokes and improve outcomes. Led by Professor Renate Schnabel, the project advocates for … Read the full press release

CHIL Receives £4.9m Investment to Spearhead Healthcare Advancements through Data Science

(IN BRIEF) The University of Liverpool’s Civic Health Innovation Labs (CHIL) has secured a substantial £4.9 million investment from the Office for Life Sciences (OLS) to drive healthcare improvements via data science. Through the ‘Data-Action Accelerator’ project, CHIL aims to … Read the full press release

ABP Southampton Raises £3000 for ANDYSMANCLUB at Charity Quiz Night

(IN BRIEF) ABP Southampton recently organized its first charity quiz night at the Port of Southampton’s Ocean Cruise terminal, raising an impressive £3000 in support of ANDYSMANCLUB (AMC), their charity of the year. Over 180 participants in 22 teams, inclujding … Read the full press release

EHRA 2024: Unveiling Groundbreaking Innovations in Arrhythmia Management

(IN BRIEF) Prepare for the latest advancements in the prevention and treatment of heart rhythm disorders at EHRA 2024, the annual congress of the European Heart Rhythm Association (EHRA), part of the European Society of Cardiology (ESC). Set to take … Read the full press release

EQT Life Sciences Portfolio Company Amolyt Pharma Acquired by Alexion, AstraZeneca Rare Diseases for $1.05 Billion

(IN BRIEF) EQT Life Sciences announces the acquisition of its portfolio company, Amolyt Pharma, by Alexion, AstraZeneca Rare Diseases, for a total deal value of $1.05 billion. This acquisition underscores Amolyt’s significant advancements in developing novel treatments for rare endocrine … Read the full press release

Evonik Vland Biotech Launches Joint Venture to Enhance Animal Gut Health Solutions

(IN BRIEF) The joint venture, Evonik Vland Biotech, established by Evonik China and Shandong Vland Biotech, officially commenced operations in Binzhou, China, aiming to bolster the market presence of probiotics for livestock gut health in the Greater China region while … Read the full press release

Evonik’s EUDRAGIT® Polymers: Pioneering Pharmaceutical Innovation for 70 Years

(IN BRIEF) Evonik’s EUDRAGIT® polymers, renowned coatings for pharmaceuticals, celebrate 70 years of revolutionizing drug delivery. With over 23,000 patents and 10,000 scientific publications, these methacrylate polymers have become industry standards, employed in formulations for modified drug release across 80 … Read the full press release

Tubulis Secures €128 Million Series B2 Financing to Advance Novel ADC Pipeline for Cancer Treatment

(IN BRIEF) Tubulis has closed an oversubscribed €128 million ($138.8 million) Series B2 financing round, co-led by EQT Life Sciences and Nextech Invest Ltd, with participation from new and existing investors including Frazier Life Sciences and Deep Track Capital. The … Read the full press release

Agfa Appoints Jeroen Spruyt as President of Radiology Solutions Division

(IN BRIEF) Effective March 13, 2024, Jeroen Spruyt is appointed as President of Agfa’s Radiology Solutions division and joins the company’s Executive Management Team. With a background in Applied Economics and an MBA from Vlerick Business School, Spruyt brings extensive … Read the full press release

Heatwaves Threaten Tsetse Fly Fertility, Raising Concerns for Disease Spread

(IN BRIEF) A groundbreaking study conducted by researchers from the University of Bristol and Stellenbosch University reveals that a single burst of hot weather significantly impacts the fertility of both female and male tsetse flies, key vectors for diseases like … Read the full press release

Health Canada Authorizes Probiotic Strain CLEPIUS™ for Alleviating Digestive Discomfort and Stress

(IN BRIEF) Health Canada has approved functional claims for Novonesis’ probiotic strain CLEPIUS™, acknowledging its efficacy in alleviating symptoms of irritable bowel syndrome (IBS) and improving quality of life in adults. The authorization encompasses a range of benefits, including relief … Read the full press release

DHL Global Forwarding Partners with kinderherzen to Transport Mobile Heart Clinic for Infants Worldwide

(IN BRIEF) DHL Global Forwarding has initiated a pro bono logistics partnership with German NGO kinderherzen, facilitating the transportation of the world’s first mobile heart clinic for infants to various countries globally. The mobile clinic, starting its journey in El … Read the full press release

Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics

(IN BRIEF) The Conference Forum announced the launch of the 8th annual Patients as Partners® Europe meeting, scheduled for May 14-15, 2024, at Plaisterers’ Hall in London, England. This event brings together pharma R&D and patient advocacy to discuss patient … Read the full press release

AI Innovation in Healthcare: Wolters Kluwer Introduces UpToDate®-Powered AI Labs

(IN BRIEF) Wolters Kluwer Health introduces AI Labs, a Clinical Generative AI (GenAI) initiative powered by UpToDate®, its trusted clinical decision support solution. AI Labs gains access to UpToDate’s comprehensive clinical content and is made available to over 100 U.S. … Read the full press release

Breakthrough Study Shows Amlitelimab’s Long-lasting Effectiveness in Atopic Dermatitis Treatment

(IN BRIEF) In a groundbreaking Phase 2b study, amlitelimab demonstrates remarkable potential in maintaining treatment response for patients with moderate to severe atopic dermatitis (AD). Presented at the American Academy of Dermatology (AAD) 2024 Conference, the study reveals sustained improvement … Read the full press release

Basilea Pharmaceutica Celebrates Milestone Payment as Cresemba® Sales Soar in Asia Pacific and China

(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN) announced a significant milestone with a USD 1.25 million payment triggered by the robust sales performance of its antifungal medication, Cresemba® (isavuconazole), in the Asia Pacific region and China by its license partner … Read the full press release

Boehringer Ingelheim and Sosei Heptares Forge Global Collaboration to Pioneer Precision Treatment for Schizophrenia

(IN BRIEF) Boehringer Ingelheim and Sosei Group Corporation (Sosei Heptares) have unveiled a global collaboration and exclusive option-to-license agreement aimed at advancing the development and commercialization of Sosei Heptares’ portfolio of first-in-class GPR52 agonists. The focus of this collaboration lies … Read the full press release

Innovative Oral Contraception Program Targets Growing Wild Boar Issue

(IN BRIEF) Researchers are launching a pioneering initiative to address the surging wild boar population across parts of Europe by administering oral contraception to the animals. With numbers of wild boar escalating rapidly and posing significant economic and environmental threats, … Read the full press release

Eni Foundation Launches Mobile Clinics Initiative to Enhance Healthcare in Remote Algerian Regions

(IN BRIEF) Eni Foundation, in collaboration with the Algerian Ministry of Health, Population and Hospital Reform, has initiated a project aimed at bolstering healthcare services in remote regions of Algeria. The endeavor, unveiled during a ceremony in Algiers, saw the … Read the full press release

Continuity and Strategy: Fresenius Management SE Proactively Extends CFO Sara Hennicken’s Mandate

(IN BRIEF) Fresenius Management SE has extended Sara Hennicken’s term as Chief Financial Officer (CFO) until 2027, two years earlier than planned, to ensure continuity in advancing the #FutureFresenius strategy. Hennicken, who joined Fresenius in 2019, has been instrumental in … Read the full press release

Fresenius Medical Care Employees Garner Prestigious Awards for Contributions to Renal Health

(IN BRIEF) Fresenius Medical Care, a leading provider of products and services for renal diseases, celebrates International Women’s Day by honoring three exceptional employees for their outstanding achievements. Ana Catalina Alvarez Elias, a Research Scientist, has been recognized as an … Read the full press release

FDA Gives Nod to Fresenius Kabi’s Tyenne®: A Dual-Format Tocilizumab Biosimilar Advancement

(IN BRIEF) Fresenius Kabi announces FDA approval of Tyenne® (tocilizumab-aazg), the first tocilizumab biosimilar offering both IV and subcutaneous formulations. This marks a significant milestone in the company’s growth strategy (#FutureFresenius) and expands treatment options for inflammatory, autoimmune diseases, and … Read the full press release

GSK Reports Positive Results from DREAMM-8 Phase III Trial of Blenrep in Multiple Myeloma Treatment

(IN BRIEF) GSK has announced encouraging findings from the interim analysis of the DREAMM-8 phase III trial evaluating Blenrep (belantamab mafodotin) in combination with pomalidomide plus dexamethasone (PomDex) compared to the standard of care, bortezomib plus PomDex, for relapsed or … Read the full press release

Novo Nordisk Hosts Capital Markets Day to Share Progress on Strategic Aspirations 2025

(IN BRIEF) Novo Nordisk is conducting a Capital Markets Day (CMD) to provide updates on its Strategic Aspirations 2025. The event will focus on various aspects, including corporate strategy, sustainability, research and development pipeline, and financial performance. Highlights include discussions … Read the full press release

Philips Tops Clarivate’s 2024 Global Innovator List for 11th Consecutive Year

(IN BRIEF) Royal Philips, a prominent figure in health technology, has once again secured its position in the 2024 Clarivate Top 100 Global Innovator™ list, marking its eleventh consecutive inclusion. With a dedication to R&D programs and collaborative efforts, Philips … Read the full press release

Biotech Acceleration: Evotec and Claris Ventures Unite to Propel Portfolio Companies Forward

(IN BRIEF) Evotec and Claris Ventures have formed a strategic partnership to accelerate the progress of biotech ventures in Claris’s portfolio into clinical trials. This collaboration allows Claris’s portfolio companies, focused on biotech ventures nearing clinical trials, streamlined access to … Read the full press release

Novo Nordisk’s Semaglutide Shows Promise in Kidney Outcomes Trial FLOW

(IN BRIEF) Novo Nordisk has announced promising headline results from the kidney outcomes trial FLOW, which compared injectable semaglutide 1.0 mg with placebo as an adjunct to standard care for people with type 2 diabetes and chronic kidney disease (CKD). … Read the full press release

What’s new in cancer care across Europe in early 2024 (1 Jan – 5 Mar 2024): Advancements, Innovations, Research, Awareness

(IN BRIEF) In early 2024, Europe’s medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer, and AstraZeneca’s Tagrisso for EGFR-mutated lung cancer. Diagnostic advancements … Read the full press release

Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment

(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release

EMA Validates Marketing Authorisation Applications for AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan in Lung and Breast Cancer Treatment

(IN BRIEF) The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for datopotamab deruxtecan (Dato-DXd), developed by AstraZeneca and Daiichi Sankyo, for the treatment of nonsquamous non-small cell lung cancer (NSCLC) and hormone receptor (HR)-positive, HER2-negative breast … Read the full press release

Empathetic Communication Found Effective in Addressing Vaccine Hesitancy, Study Shows

(IN BRIEF) A groundbreaking international study led by the University of Bristol reveals the effectiveness of empathetic correction of misinformation in improving attitudes towards vaccination, particularly among vaccine-hesitant individuals. The research, published in Health Psychology, highlights the significance of empathetic … Read the full press release

Genetic Study Reveals Potential for Tailored Breast Cancer Screening

(IN BRIEF) A recent genetic study conducted by researchers at the University of Helsinki suggests that genetic risk information could revolutionize breast cancer screening, potentially benefiting one in ten women. The study indicates that a comprehensive genetic risk profile could … Read the full press release

Prosus Ventures Backs Kismet with $8.2M Seed Investment for Healthcare Innovation

(IN BRIEF) Kismet, a healthcare startup, has secured $8.2 million in seed funding led by Prosus Ventures and Airtree Ventures, bringing its total financing to $10.8 million since its founding in February 2023. The funding will accelerate Kismet’s mission to … Read the full press release

Novartis Unveils Promising Results from SMART Study: Zolgensma’s Efficacy Confirmed in Older and Heavier SMA Patients

(IN BRIEF) Novartis has presented compelling data from the SMART study, reinforcing the clinical advantages of Zolgensma® (onasemnogene abeparvovec) in treating spinal muscular atrophy (SMA) patients weighing ≥ 8.5 kg to ≤ 21 kg, with a mean age of 4.69 … Read the full press release

The European companies at MWC Barcelona 2024: AI, 5G, VR, XR, Cybersecurity, Digital Transformation, Entertainment, etc.

(IN BRIEF) At the Mobile World Congress (MWC) Barcelona 2024, European companies showcased a wide array of innovations and strategic partnerships that underscored their commitment to driving digital transformation and enhancing connectivity across various sectors. The key topics discussed by … Read the full press release

Driving Innovation: Henkel Spotlights Self-Regulating PTC Heaters and More at LOPEC 2024

(IN BRIEF) Henkel, a leading provider of printed electronics materials, is set to showcase its latest innovations at the LOPEC trade show. They will unveil their functional materials tailored for smart surfaces, healthcare, and connectivity applications. The focus will be … Read the full press release

Eckert & Ziegler’s GalliaPharm® Generator Powers Groundbreaking Cancer Diagnostic Trial in Japan

(IN BRIEF) Eckert & Ziegler, in collaboration with Novartis Pharma K.K., is expanding Ga-68 labeled diagnostics in Japan through a clinical trial approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Utilizing Eckert & Ziegler’s GalliaPharm® generator, the trial … Read the full press release

Leading Healthcare Giant Fresenius Establishes ESG Advisory Board

(IN BRIEF) Fresenius, a global healthcare group, has appointed an independent advisory board to focus on sustainability issues. Comprising four experts from various fields, the board will support the development of Fresenius’ sustainability strategy. This move reflects Fresenius’ commitment to … Read the full press release

trinamiX Unveils Groundbreaking Consumer Spectroscopy Solution at MWC Barcelona 2024

(IN BRIEF) trinamiX GmbH debuts its latest innovation, the Consumer Spectroscopy solution, at the Mobile World Congress in Barcelona. This cutting-edge technology integrates a near-infrared (NIR) spectrometer into a smartphone reference design powered by Qualcomm’s Snapdragon® 8 Gen 3 platform, … Read the full press release

Voydeya Recommended for EU Marketing Authorization as PNH Treatment Add-On

(IN BRIEF) Voydeya (danicopan), a first-in-class oral Factor D inhibitor, has been recommended for marketing authorization in the European Union (EU) as an add-on to ravulizumab or eculizumab for adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who experience residual haemolytic … Read the full press release